» Articles » PMID: 38164567

Dentate Gyrus Granule Cells Show Stability of BDNF Protein Expression in Mossy Fiber Axons with Age, and Resistance to Alzheimer's Disease Neuropathology in a Mouse Model

Overview
Journal eNeuro
Specialty Neurology
Date 2024 Jan 2
PMID 38164567
Authors
Affiliations
Soon will be listed here.
Abstract

Brain-derived neurotrophic factor (BDNF) is important in the development and maintenance of neurons and their plasticity. Hippocampal BDNF has been implicated in Alzheimer's disease (AD) because hippocampal levels in AD patients and AD animal models are often downregulated, suggesting that reduced BDNF contributes to AD. However, the location where hippocampal BDNF protein is most highly expressed, the mossy fiber (MF) axons of dentate gyrus granule cells (GCs), has been understudied, and not in controlled conditions. Therefore, we evaluated MF BDNF protein in the Tg2576 mouse model of AD. Tg2576 and wild-type (WT) mice of both sexes were examined at 2-3 months of age, when amyloid-β (Aβ) is present in neurons but plaques are absent, and 11-20 months of age, after plaque accumulation. As shown previously, WT mice exhibited high levels of MF BDNF protein. Interestingly, there was no significant decline with age in either the genotype or sex. Notably, MF BDNF protein was correlated with GC ΔFosB, a transcription factor that increases after 1-2 weeks of elevated neuronal activity. We also report the novel finding that Aβ in GCs or the GC layer was minimal even at old ages. The results indicate that MF BDNF is stable in the Tg2576 mouse, and MF BDNF may remain unchanged due to increased GC neuronal activity, since BDNF expression is well known to be activity dependent. The resistance of GCs to long-term Aβ accumulation provides an opportunity to understand how to protect vulnerable neurons from increased Aβ levels and therefore has translational implications.

References
1.
Holsinger R, Schnarr J, Henry P, Castelo V, Fahnestock M . Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res. 2000; 76(2):347-54. DOI: 10.1016/s0169-328x(00)00023-1. View

2.
Callahan M, Lipinski W, Bian F, Durham R, Pack A, Walker L . Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol. 2001; 158(3):1173-7. PMC: 1850367. DOI: 10.1016/s0002-9440(10)64064-3. View

3.
Barde Y, Edgar D, Thoenen H . Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982; 1(5):549-53. PMC: 553086. DOI: 10.1002/j.1460-2075.1982.tb01207.x. View

4.
Harte-Hargrove L, Varga-Wesson A, Duffy A, Milner T, Scharfman H . Opioid receptor-dependent sex differences in synaptic plasticity in the hippocampal mossy fiber pathway of the adult rat. J Neurosci. 2015; 35(4):1723-38. PMC: 4308610. DOI: 10.1523/JNEUROSCI.0820-14.2015. View

5.
Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y . Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry. 2008; 69(7):1104-11. DOI: 10.4088/jcp.v69n0710. View